measuregroup/AID266339

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103223949_AID266339_PMID16513348_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103490519_AID266339_PMID16513348_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103490110_AID266339_PMID16513348_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103199497_AID266339_PMID16513348_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103174500_AID266339_PMID16513348_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID128875
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Antiangiogenic activity against HUVEC cells by tube formation assay at 100 uM
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103174500 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103490519 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103223949 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103490110 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103199497
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID266339

Total number of triples: 15.